Quantcast

Latest Hepatocellular carcinoma Stories

2014-10-16 08:31:16

SAN ANTONIO, Texas, October 16, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, today announced that Melanie Thomas, MD, MS, a recognized worldwide leader in the field of liver cancer, will join the company as Medical Advisor. Dr. Thomas most recently held the Grace E. DeWolff Chair in Gastrointestinal Oncology at the Medical University of South Carolina and served as Associate Director of Clinical...

2014-10-09 08:27:33

SAN ANTONIO, Texas, October 9, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, today announced that patient enrollment has been completed in the company's Phase II clinical trial in patients with liver cancer (hepatocellular carcinoma). Formal results of the study are expected to be available during the first quarter of 2015. "We are grateful to the trial investigators for their efforts, as well as the...

2014-10-07 08:28:45

PETACH TIKVA, Israel, Oct. 7, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced the Company's CEO, Dr. Pnina Fishman, will co-chair the Cancer Therapeutics session of the 19th World Congress on Advances in Oncology. The conference will take place in Athens, Greece, from October 9-11, 2014. In addition to co-chairing...

2014-09-30 08:31:31

CF102 has shown to induce healthy liver cell proliferation resulting in improved liver status PETACH TIKVA, Israel, Sept. 30, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, today announced the United States Patent and Trademark Office has issued a patent to the Company which covers its drug candidate, CF102, in the treatment of...

2014-09-29 08:32:29

TEL-AVIV, Israel, Sept. 29, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it purchased 60 EndoPAT(TM) devices and accessories from Itamar Medical Ltd. (TASE: ITMR) ("Itamar Medical"), a publicly-traded medical device company whose technology has...

2014-09-24 04:21:41

WHIPPANY, N.J., Sept. 24, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that data from its oncology portfolio, including Stivarga(®) (regorafenib) tablets, NEXAVAR(®) (sorafenib) tablets and Xofigo(®) (radium Ra 223 dichloride) injection, will be presented at the European Society for Medical Oncology (ESMO) 2014 Congress taking place September 26 - 30 in Madrid, Spain. "Bayer's presence at this global medical congress demonstrates our commitment to research...

2014-09-17 08:29:05

DUBLIN, Sept. 17, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Hepatitis C Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Hepatitis C is a liver disease caused by infection due to hepatitis C virus. Hepatitis C infection predominantly affects the liver; however, other parts of the body are also affected such as the brain and the digestive system. Hepatitis C virus is an RNA virus belonging to the family...

2014-09-10 12:27:54

ViewRay's MRIdian System Directly Tracks Tumor Motion Continuously During Treatment CLEVELAND, Sept. 10, 2014 /PRNewswire/ -- The MRIdian(TM) (me-rid-i-an) system from ViewRay(TM), a privately held medical device company, is now being used to treat patients at the University of Wisconsin Carbone Cancer Center in Madison, Wisconsin, the second clinical group in the world to treat patients with MRI-guided radiation therapy. With yesterday's treatment, the center also became the first...

2014-09-09 12:29:46

Argon Medical Expands its Comprehensive Biopsy Portfolio with the Addition of the TLAB® Transjugular Liver Biopsy Instrument PLANO, Texas, Sept. 9, 2014 /PRNewswire/ -- Argon Medical Devices, Inc. announced today that it has acquired Promex Technologies, LLC (d/b/a US Biopsy), a manufacturer of soft-tissue biopsy products including the TLAB® Transjugular Liver Biopsy Instrument ("TLAB"). The acquisition establishes Argon Medical as one of two companies competing in the...

2014-09-09 12:26:46

Clinical Trials Will Continue to Play a Key Role in this Growing Market, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 9, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States interventional oncology device market will see strong growth, reaching a value of $760 million by 2023. Rising cancer incidence rates combined with the ineffectiveness of chemotherapy and demand for less invasive procedures will support interventional oncology device...


Latest Hepatocellular carcinoma Reference Libraries

Hepatitis B
2013-02-25 09:11:23

Image Caption: This electron micrograph reveals the presence of hepatitis-B virus HBV "Dane particles", or virions. Credit: CDC/Wikipedia Hepatitis B: What Is It? Hepatitis simply means a swelling or inflammation of the liver. The type hepatitis that a person contracts (there are 5 common forms) affects their long-term prognosis. The most common and most severe of these different types of liver infection is Hepatitis B, which is caused by the hepatitis B virus (HBV). It is typically...

45_36624a455e3cd9a4152b7670308f0ffa
2011-01-20 19:14:56

Hepatitis B virus, HBV, is a part of the Hepadnaviridae family of viruses. HBV can lead to cirrhosis and hepatocellular carcinoma and has been linked to pancreatic cancer. It is classified as a species of the Orthohepadnavirus. Similar viruses have been found worldwide in great apes and monkeys. There a few different genotypes and they all differ by at least 8% of the sequence and have distinct geographical distributions and this has been associated with anthropological history. Type A is...

0_9255b919f71eff1fd4202c1dbb1795d2
2011-01-12 15:49:29

Hepadnaviruses can cause liver infections in humans and animals. The two recognized genera are Genus Orthohepadnavirus and Genus Avihepadnavirus. It has a small genome of partially double-stranded, partially single stranded circular DNA. It is a group 7 virus that uses an RNA intermediate during replication. Most people who come into contact with the virus are able to clear the infection alone although some cannot and usually progress to fulminant hepatitis. It can cause sever liver...

More Articles (3 articles) »
Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.